Annexon
Presence
Annexon is a company listed under the stock ticker ANNX (US).
Executives
View the org chart displaying its 14 main executives
Most searched biographies at Annexon
- Douglas Love, Director, President and Chief Executive Officer
- Thomas Wiggans, Chairman of the Board
- Jung Choi, Board Member
Popular executive movements at Annexon
- Jamie Dananberg has joined the company as Chief Medical Officer (posted on August 2 2023).
Create your alert
to follow the executive moves at Annexon.
Biotechnology
Annexon has 2,279 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
Popular contacts in Biotechnology
News
Press releases by Annexon
- Annexon Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights | Annexon Inc.
- Annexon Biosciences Expands Leadership Team with the Appointment of Michael Overdorf as Chief Business Officer | Annexon Inc.
- Annexon Announces Closing of Initial Public Offering | Annexon Inc.
- Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics | Annexon Inc.
- Annexon Announces Pricing of Initial Public Offering | Annexon Inc.
- News Releases | Annexon Inc.
- View more press releases Close
Social media about Annexon
- Annexon on Wikipedia, Google News & Yahoo Finance
- Annexon on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Jung Choi 
